Levels of YKL-40 in Cerebrospinal Fluid and Serum of Newly Diagnosed Patients with Relapsing-Remitting Multiple Sclerosis

Purpose: Chitinase-3-like protein 1 (CHI3L1 or YKL-40), novel inflammatory glycoprotein predominantly produced by reactive astrocytes. The aim of this study was to investigate YKL-40 levels in serum and cerebrospinal fluid (CSF) of newly diagnosed relapsingremitting multiple sclerosis (RRMS) patients. Materials and Methods: This study was conducted at the Neurology Clinic of Recep Tayyip Erdogan University Faculty of Medicine Training and Research Hospital between October 2012 and November 2016. A total of 50 participants, including 30 newly diagnosed and untreated RRMS patients (18 females, 12 males, age range 18-40 year) and 20 controls (12 females, 8 males, age range 20-40 year) were included in the study. CSF and serum YKL-40 levels of RRMS patients and controls were measured by ELISA. Results: CSF YKL-40 levels of RRMS patients were significantly higher than in controls. (respectively,168.8±28.3 ng/ml and 70.1±14.3 ng/ml, p

Authors

Institutions

Publication Details

Journal
Ahi Evran Medical Journal
Published
2025-12-22
DOI
https://doi.org/10.46332/aemj.1640948
Primary Topic
Studies on Chitinases and Chitosanases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Levels of YKL-40 in Cerebrospinal Fluid and Serum of Newly Diagnosed Patients with Relapsing-Remitting Multiple Sclerosis

Medine Cumhur Cüre, Aynur Kırbaş, Serkan Kırbaş
Ahi Evran Medical Journal
Studies on Chitinases and Chitosanases
article

Levels of YKL-40 in Cerebrospinal Fluid and Serum of Newly Diagnosed Patients with Relapsing-Remitting Multiple Sclerosis

Medine Cumhur Cüre, Aynur Kırbaş, Serkan Kırbaş
article en

Abstract

Purpose: Chitinase-3-like protein 1 (CHI3L1 or YKL-40), novel inflammatory glycoprotein predominantly produced by reactive astrocytes. The aim of this study was to investigate YKL-40 levels in serum and cerebrospinal fluid (CSF) of newly diagnosed relapsingremitting multiple sclerosis (RRMS) patients. Materials and Methods: This study was conducted at the Neurology Clinic of Recep Tayyip Erdogan University Faculty of Medicine Training and Research Hospital between October 2012 and November 2016. A total of 50 participants, including 30 newly diagnosed and untreated RRMS patients (18 females, 12 males, age range 18-40 year) and 20 controls (12 females, 8 males, age range 20-40 year) were included in the study. CSF and serum YKL-40 levels of RRMS patients and controls were measured by ELISA. Results: CSF YKL-40 levels of RRMS patients were significantly higher than in controls. (respectively,168.8±28.3 ng/ml and 70.1±14.3 ng/ml, p

Ahi Evran Medical JournalVol. 9(3)
Ahi Evran University (TR), Gazi Hastanesi (TR), Özel Trakya Hastanesi (TR)
Good health and well-being
Openalex Percentile: Top 36%
Studies on Chitinases and Chitosanases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.